Charles Matine - Director at Bionik Laboratories Corp.

Issuer-level insider activity

Role
Director
Issuer ticker
BNKL
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Charles Matine since 16 Aug 2025

Reported holdings for Charles Matine in Bionik Laboratories Corp.

Form 4 holding Director

Bionik Laboratories Corp.

Security class
Common Stock, par value $0.001 per share
Shares / value
206,985
Estimated value
$124,191
Report date
09 Jun 2023
Price
$0.6000
Ownership
Direct

Transaction history for Charles Matine in Bionik Laboratories Corp.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .